Skip to main content Skip to main navigation menu Skip to site footer
MedNext Journal of Medical and Health Sciences
Review
DOI: 10.54448/mdnt23S205
Submitted: 11-04-2023
Published: 11-04-2023

Osteonecrosis of the jaw with the use of bisphosphonates and treatment with laser therapy and magnetotherapy: a concise systematic review

UNORTE - University Center of Northern São Paulo, Dentistry department, São José do Rio Preto, São Paulo, Brazil
UNORTE - University Center of Northern São Paulo, Dentistry department, São José do Rio Preto, São Paulo, Brazil
UNORTE - University Center of Northern São Paulo, Dentistry department, São José do Rio Preto, São Paulo, Brazil
UNORTE - University Center of Northern São Paulo, Dentistry department, São José do Rio Preto, São Paulo, Brazil / UNIPOS - Post graduate and continuing education, Dentistry department, São José do Rio Preto, São Paulo, Brazil
Bisphosphonates Osteonecrosis Jaw Treatments Laser therapy Magnetotherapy

Abstract

Introduction: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) has been increasing, mainly as a consequence of the treatment of osteoporosis in elderly women. During bone resorption, bisphosphonates (BP) are taken into osteoclasts and exhibit cytotoxicity, producing a long-lasting anti-bone resorptive effect. several energy-based devices have been used with substantial clinical improvement in the treatment. Devices are widely used in various types of treatment, such as LASER, LED, TEMs, infrared devices, Ultrasound, and radiofrequency, among others. Objective: It was to analyze the main findings and weave approaches of scientific evidence of the occurrence of osteonecrosis by the use of bisphosphonates, as well as the possible treatments, highlighting laser therapy and magnetotherapy. Methods: The present study was followed by a systematic review model (PRISMA). The search strategy was performed in the PubMed, Cochrane Library, Web of Science and Scopus, and Google Scholar databases. The Cochrane Instrument was used to assess the risk of bias from the included studies. The present study was carried out from December 2022 to March 2023. Results and Conclusion: A total of 138 articles were found. Initially, duplicate articles were excluded. After this process, the abstracts were evaluated and a new exclusion was performed based on the GRADE Instrument and Risk of Bias. A total of 58 articles were fully evaluated and 26 were included and discussed in this study. It was concluded that photobiomodulation therapy and magnetotherapy showed safety and efficacy in the treatment of BRONJ, through the reduction of phlogistic signs, faster healing, and reduction of postoperative morbidity. Only four applications of low-intensity laser and magnetotherapy were enough to reduce the inflammatory process in the surgical wound, stimulate the tissue repair process and provide postoperative analgesia.

Metrics

Metrics Loading ...

References

  1. Endo Y, Funayama H, Yamaguchi K, Monma Y, Yu Z, Deng X, Oizumi T, Shikama Y, Tanaka Y, Okada S, Kim S, Kiyama T, Bando K, Shima K, Suzuki H, Takahashi T. [Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates]. Yakugaku Zasshi. 2020;140(1):63-79. Japanese. doi: 10.1248/yakushi.19-00125.
  2. Chien HI, Chen LW, Liu WC, Lin CT, Ho YY, Tsai WH, Yang KC. Bisphosphonate-Related Osteonecrosis of the Jaw. Ann Plast Surg. 2021 Feb 1;86(2S Suppl 1):S78-S83. doi: 10.1097/SAP.0000000000002650.
  3. McCadden L, Leonard CG, Primrose WJ. Bisphosphonate-induced osteonecrosis of the ear canal: our experience and a review of the literature. J Laryngol Otol. 2018 Apr;132(4):372-374. doi: 10.1017/S0022215118000324.
  4. Sogacheva VV, Syomkin VA. Bisfosfonatnye osteonekrozy chelyustei [Bisphosphonate-related osteonecrosis of the jaws]. Stomatologiia (Mosk). 2022;101(6):85-90. Russian. doi: 10.17116/stomat202210106185.
  5. Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg. 2022 May;80(5):920-943. doi: 10.1016/j.joms.2022.02.008.
  6. Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ. Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS. J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888.
  7. Wang M, Wu YF, Girgis CM. Bisphosphonate Drug Holidays: Evidence From Clinical Trials and Real-World Studies. JBMR Plus. 2022 May 24;6(6):e10629. doi: 10.1002/jbm4.10629.
  8. Priyadarshini V, Ramachandra SS, Ganganna A. Awareness and Attitude Among Physicians' About Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ): A Cross-sectional study. Curr Drug Saf. 2022 May 14. doi: 10.2174/1574886317666220514160507.
  9. Vieira AE, Repeke CE, Ferreira Junior Sde B, Colavite PM, Biguetti CC, Oliveira RC, Assis GF, Taga R, Trombone AP, Garlet GP. Intramembranous bone healing process subsequent to tooth extraction in mice:m icrocomputedtomography, histomorphometric and molecular characterization. PLoS One. 2015 May 29;10(5):e0128021. doi: 10.1371/journal.pone.0128021. eCollection 2015.
  10. Vermeer JA, Renders GA, Everts V. Osteonecrosis of the Jaw-a Bone SiteSpecific Effect of Bisphosphonates. Curr Osteoporos Rep. 2016 Oct;14(5):219- 25. doi: 10.1007/s11914-016-0318-z.
  11. Schiodt M, Otto S, Fedele S, Bedogni A, Nicolatou-Galitis O, Guggenberger R, Herlofson BB, Ristow O, Kofod T. Workshop of European Task Force on Medication Related Osteonecrosis of the Jaw.Current challenges. Oral Dis. 2019 Jul 20. doi: 10.1111/odi.13160.
  12. Kuroshima S, Sasaki M, Sawase T. Medication-related osteonecrosis of the jaw: A literature review. J Oral Biosci. 2019 Jun;61(2):99-104. doi: 10.1016/j.job.2019.03.005.
  13. Goss AN. Osteonecrosis of the jaw and denosumab. Aust Prescr. 2022 Dec;45(6):208-209. doi: 10.18773/austprescr.2022.066.
  14. R. Fliefel, M. Tro¨ltzsch, J. Ku¨hnisch, M. Ehrenfeld, S. Otto: Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int. J. Oral Maxillofac. Surg. 2015;
  15. S Otto, Medication related osteonecrosis of the jaws 2016. ISBN 978-3-662- 43732-2. DOI 0.1007/978-3-662-43733-9. Springer Heidelberg New York Dordrecht London
  16. Vescovi, P., Meleti, M., Merigo, E., Manfredi, M., Fornaini, C., Guidotti, R., & Nammour, S. (2013). Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd: YAG low-level laser therapy. Medicina Oral, Patología Oral Y Cirugía Bucal, 18(4), e680–e685. http://doi.org/10.4317/medoral.18812
  17. Otto, Sven. Antiresorptive drug-related osteonecrosis of the jaw (ARONJ)-a guide to research. Eds. Kenneth E. Fleisher, and Risto Kontio. Thieme, 2016, AO Foundation, ISBN: 978-3-905363-10-4, Davos, Switzerland.
  18. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa)induced avascular necrosis Treatment strategies and outcomes of BRONJ 579 of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115–7.
  19. Weber, J. B. B., Camilotti, R. S., & Ponte, M. E. (2016). Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review. Lasers in medical science, 31(6), 1261-1272. DOI 10.1007/s10103-016-1929-4
  20. Meyer, P. F., Paiva, A., Cavalcanti, S., da Silva, E. M., da Silva, R. M. V., de Souza Costa, L., & Ronzio, O. A. (2011). Magnetoterapia: é possível este recurso fazer parte da rotina do fisioterapeuta brasileiro?. Arquivos Brasileiros de Ciências da Saúde, 36(1).
  21. Silva, R. M. V. D., Xavier, W. J. C., Dantas Neto, R. G., Azevedo, V. M. D., Nascimento, B. J. R. D., Oliveira, J. F. D., & Meyer, P. F. (2016). Efeitos da magnetoterapia no tratamento da dor na osteoartrose de joelho. ConScientiae Saúde, 15(2), 281-287.
  22. Ferreira Jr LH Jr, Mendonça Jr KD Jr, Chaves de Souza J, Soares Dos Reis DC, do Carmo Faleiros Veloso Guedes C, de Souza Castro Filice L, Bruzadelli Macedo S, Soares Rocha F. Bisphosphonate-associated osteonecrosis of the jaw. Minerva Dent Oral Sci. 2021 Feb;70(1):49-57. doi: 10.23736/S2724- 6329.20.04306-X.
  23. AAOMS AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS POSITION PAPER.Medication-RelatedOsteonecrosisoftheJaw – 2014 Update. Ilinois,abr./2014.http://www.aaoms.org/docs/position_papers/mronj_position_pa per.pdf?pdf=MRONJ-Position-Paper.
  24. Li FL, Wu CB, Sun HJ, Zhou Q. Effectiveness of laser-assisted treatments for medication-related osteonecrosis of the jaw: a systematic review. Br J Oral Maxillofac Surg. 2020 Apr;58(3):256-267. doi: 10.1016/j.bjoms.2019.12.001.
  25. Lorenzo-Pouso, Alejandro I., et al. Biomarkers to predict the onset of biphosphonate-related osteonecrosis of the jaw: A systematic review. Medicina oral, patologia oral y cirugia buccal. 2019, 24.1: e26.
  26. Vieira JGH. Diagnóstico laboratorial e monitoramento das doenças osteometabólicas. Jornal Brasileiro de Patologia e Medicina Laboratorial, 2007, 43(2), 75-82.

How to Cite

Arede, D. P., Beijo, A. S., Martinez, D. M. de P., & Beneti, I. M. (2023). Osteonecrosis of the jaw with the use of bisphosphonates and treatment with laser therapy and magnetotherapy: a concise systematic review. MedNEXT Journal of Medical and Health Sciences, 4(S2). https://doi.org/10.54448/mdnt23S205